Loncar Launches China BioPharma ETF on NASDAQ Exchange

Life Science

CrownBio Acquires Rights to Drug Development Models from Shanghai Model Organisms

Life Science

Introducing New Featured Companies on NAI500! – Golden Dawn Minerals, China Minerals, Namaste Technologies, Glance Technologies

Cannabis, Life Science

Magnolia Neurosciences Launches with $31 Million

Life Science

CANbridge Approved for China Phase Ib/III Trial of Esophageal Cancer Drug

Life Science

Sihuan Pharma Starts China Phase II Lung Cancer Trial

Life Science

Maple Leaf Green World CEO Interview with INN: Near-term Cultivation and Sale of Cannabis for the Medicinal Market

Life Science

JD.Com, Zhejiang Zhenyuan Pair to Build Drug Distribution Center

Life Science

Amazon, Alphabet, Microsoft and other tech giants want to fix one of the most broken things about health care

Life Science

BIOREM Announces Orders Totalling $12.2 million – Including $4 million in China

Life Science

Haisco Invests $10 Million in Pneuma Respiratory; Acquires Rights to Asthma/COPD Inhaler

Life Science

Amicus Therapeutics receives U.S. approval for Fabry disease drug

Life Science

Oregon marijuana firm Cura expands into Canada, eyes overseas growth

Cannabis, Life Science

Alnylam’s gene silencing drug wins FDA approval

Life Science

Astellas Expands Gene Therapy Investment, Acquires U.K.-based Quethera for $109 Million

Life Science